N
IMUX icon

Nuveen’s Immunic IMUX Stock Holding History

Nuveen’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,372
Closed -$830K – 3368
2022
Q1 		$830K Sell
7,372
-166
-2% -$19.2K ﹤0.01% 2874
2021
Q4 		$638K Sell
7,538
-561
-7% -$50.5K ﹤0.01% 3004
2021
Q3 		$763K Buy
8,099
+607
+8% +$59.7K ﹤0.01% 3079
2021
Q2 		$919K Buy
7,492
+3,307
+79% +$457K ﹤0.01% 3039
2021
Q1 		$667K Sell
4,185
-11,524
-73% -$1.95M ﹤0.01% 3020
2020
Q4 		$2.4M Sell
15,709
-814
-5% -$146K ﹤0.01% 2416
2020
Q3 		$3.07M Buy
16,523
+14,618
+767% +$2.39M ﹤0.01% 2170
2020
Q2 		$231K Buy
+1,905
New +$194K ﹤0.01% 3078

Other funds holding IMUX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Nuveen's IMUX Position: Q2 2022 in Review

Nuveen sold out of Immunic (IMUX) in Q2 2022, closing a stake of 7,372 shares — an estimated $830K sold.

Nuveen first reported a position in IMUX in Q2 2020 and held it in 8 quarters. The position peaked at $3.07M in Q3 2020. 72 funds tracked by Wall St. Rank hold IMUX as of Q2 2022.

  • Nuveen reported no remaining Immunic position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 7,372 Immunic shares in Q2 2022, an estimated $830K.
  • Nuveen first reported a position in Immunic in Q2 2020 and held it in 8 quarters.
  • Nuveen's Immunic position peaked at $3.07M in Q3 2020.
  • 72 funds tracked by Wall St. Rank held Immunic as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.